Question

A 60-year-old woman with invasive breast cancer is considered for adjuvant therapy. Tumor is ER-positive. Which drug is typically offered as adjuvant endocrine therapy in a postmenopausal woman?

Accepted Answer

Anastrozole (aromatase inhibitor)

Answer

Tamoxifen

Answer

Trastuzumab

Answer

Chemotherapy with cyclophosphamide

Answer

Ovarian ablation

Practice question

A 60-year-old woman with invasive breast cancer is considered for adjuvant therapy. Tumor is ER-positive. Which drug is typically offered as adjuvant endocrine therapy in a postmenopausal woman?